Meet us at the ERA-EDTA Congress in Paris!
TauroLock™ solutions advance the well-being of patients suffering from kidney failure.
TauroLock™ solutions protect patients carrying central-venous catheters during cancer treatments.
TauroLock™ solutions facilitate the process of parenteral nutrition for patients at all ages.
TauroLock™ is suitable for instillation in all central-venous access systems. It prevents the formation of bacterial biofilms and improves the patency rate.
TauroLock™-Hep100 has proven helpful for patients who previously relied on heparin-based lock solutions. Central-venous catheters remain infection-free and work properly at a high patency rate.
TauroLock™-HEP500 meets the particular needs of dialysis patients. It maintains a good flow rate and prevents catheter-related infections as well as occlusions.
TauroLock™-U25.000 ensures a particularly strong protection against catheter-related complications. It contains taurolidine, 4 % citrate, and 25,000 IU of urokinase.
NutriLock™ is the right option for those in need of a heparin-free and citrate-free lock solution. Based on the antimicrobial agent taurolidine, it provides a reliable protection against catheter-associated infections.